PDF4PRO ⚡AMP

Modern search engine that looking for books and documents around the web

Example: biology

ANNUAL REPORT 2017 - viforpharma.com

ANNUAL . REPORT . 2017 . ANNUAL REPORT 2017 . AT A GLANCE. Guidance raised at half-year, continued good performance in H2. led to strong full-year results Net sales CHF 1, million, up on a constant currency basis EBITDA CHF million, up excluding Veltassa launch costs Cash net of debt of CHF million Transformation into a pure-play pharmaceutical company successfully completed Separation of Galenica Sant via initial public offering (IPO). Etienne Jornod re-elected as Executive Chairman with remuneration exclusively in shares blocked until 2020. Change of name from Galenica Group to Vifor Pharma Group New Executive Committee appointed Operational headquarters transferred from Bern to Zurich Reported net sales growth of Ferinject + for full year 2017 .

Vifor Pharma Ltd. Annual Report 2017 ExECUTiVE MESSAGE 4 172 ExECUTiVE CHAiRMAN Dear Shareholder, It is with great pleasure that I deliver my message as Executive Chairman for the first

Loading..

Tags:

  First, 2017

Information

Domain:

Source:

Link to this page:

Please notify us if you found a problem with this document:

Spam in document Broken preview Other abuse

Transcription of ANNUAL REPORT 2017 - viforpharma.com

Related search queries